


Share on
305 views
1 Inquiries
Minimum order quantity: 1 Box
Open to price negotiation
Supplier Country: Germany
Export market: Not specified
Key Takeaways

4.8
Germany
Distributor/Wholesaler, Trading Company
Dahlmannstraße 4, 10629 Berlin, Germany, Berlin, Berlin 10629
Inquiry Open Rate
89%
Total inquiries received
45
Inquiries Read
40
Year Established
2006
Verification information
Verify business documents
By Freshdi Verification System
Verify work email
By Freshdi.com
Verify phone number
Buyer Verification Team
Verify account email
By Freshdi.com
External Validation
Company Address
Supplier confirmed with Freshdi
No reviews yet
Be the first to share your experience - your feedback helps other buyers trade with confidence.
Skyrizi is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment
Order Skyrizi Online
Skyrizi is a prescription medicine used to treat moderate to severe plaque psoriasis in adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (ultraviolet or UV light) treatment. Skyrizi is also used to treat active psoriatic arthritis and moderate to severe Crohn's disease. Skyrizi contains risankizumab-rzaa, a monoclonal antibody that targets a protein in the body called interleukin-23 (IL-23), helping to reduce inflammation.
Skyrizi is an injectable solution that provides targeted relief for several chronic inflammatory conditions. Administered under the skin, it is typically given once every 12 weeks after the initial two starter doses. It is critical to follow your healthcare provider's instructions and complete the full course of medication to experience optimal results.
Skyrizi is developed and marketed by AbbVie, a global biopharmaceutical company with a focus on science-driven healthcare innovation. AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.
These images provide an accurate representation of Skyrizi packaging and appearance. Please ensure you confirm packaging with authorized sources before making any decisions regarding your medication.
Skyrizi (risankizumab-rzaa) is an FDA-approved prescription medicine used to treat moderate to severe plaque psoriasis in adults who may benefit from taking injections or other systemic therapies. Skyrizi helps relieve symptoms such as scaling, redness, and itching by targeting the source of inflammation in the body and working to block a specific protein (interleukin-23) involved in the immune system response that causes psoriasis.
Skyrizi is a humanized immunoglobulin G1 (IgG1) monoclonal antibody designed to selectively block interleukin 23 (IL-23) by binding to its p19 subunit. This helps to reduce inflammation in individuals with plaque psoriasis. The treatment is administered as a subcutaneous injection, typically once every 12 weeks after two starter doses at weeks 0 and 4. It is a long-acting medication with demonstrated effectiveness in clinical studies showing significant improvement in skin clearance and quality of life for patients. Skyrizi is manufactured using recombinant DNA technology in Chinese hamster ovary cells.
You are viewing details for Order Skyrizi bulk order online. The information provided here is either posted directly by the supplier, who is responsible for its accuracy, or collected by Freshdi AI from publicly available sources. Freshdi strives to make product information as useful and reliable as possible, but we do not guarantee complete accuracy. If you notice any incorrect or misleading details, please use the Report Product option so our team can review and address it quickly.

![]()
4.8
Rohan Ludwig (Sale/ Marketing/ Sourcing Manager)
Active
Year Established: 2006
Business type
Distributor/Wholesaler, Trading Company
Across Pharmaceuticals, the wider group Prescription Medication belongs to, Freshdi lists 6 active supply listings from 5 suppliers in 5 countries, as of 20 November 2026. Prescription Medication belongs to Pharmaceuticals, whose suppliers on Freshdi come from 5 countries, led by Cyprus at 20.0%, as of 20 November 2026.